DA Davidson Maintains Neutral on Usana Health Sciences, Lowers Price Target to $38
Portfolio Pulse from Benzinga Newsdesk
DA Davidson analyst Linda Bolton Weiser maintains a Neutral rating on Usana Health Sciences (NYSE:USNA) and lowers the price target from $46 to $38.
July 25, 2024 | 10:53 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
DA Davidson analyst Linda Bolton Weiser maintains a Neutral rating on Usana Health Sciences and lowers the price target from $46 to $38.
The lowered price target from $46 to $38 by DA Davidson suggests a less optimistic outlook for Usana Health Sciences, which could negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100